![Eugene Marcantonio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eugene Marcantonio served as the President, Director, and Chief Medical Officer at Rycarma Therapeutics, Inc. from 2017 to 2021.
He holds a doctorate degree from New York University School of Medicine.
| Unternehmen | Position | Ende |
|---|---|---|
Rycarma Therapeutics, Inc.
 Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
